BOSTON, Oct. 2, 2020 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative hematology solutions to drive better patient outcomes, ...
BOSTON, June 22, 2023 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions to drive better patient outcomes, today ...
BRAINTREE, Mass., March 28, 2018 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for enhancement of its NexSys PCS™ ...
Zacks Investment Research on MSN
Is it apt to retain Haemonetics stock in your portfolio now?
Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback